To give you an idea, know that the FDA recommends semaglutide (Wegovy) for weight loss if you meet one of the following criteria: Your BMI is 30 or higher (classified as obesity) Your BMI is 27 or higher (overweight) You have at least one weight-related condition, such as high blood pressure, type 2 diabetes, and high cholesterol Now, you should not take semaglutide if you have: A history of medullary thyroid cancer Multiple endocrine neoplasia syndrome type 2 (MEN2) A history of pancreatitis Gallbladder disease If youre considering semaglutide for weight loss, the first step is to consult your primary care physician or visit a weight loss clinic
The highest dose studied in Phase 2, producing up to 24.2% average weight loss at 48 weeks
Men should be taught to clean the injection site (abdomen or thigh) with alcohol, pinch the skin, and inject at a 90-degree angle (if using the autoinjector, its as simple as pressing it against the skin and hitting the button)
By FormBlends Editorial Research|Source reviewed by FormBlends Medical Team|| Source Reviewed Written by FormBlends Editorial Research Checked against primary sources by FormBlends Medical Team In This Article This article is part of our Provider Comparisons collection
For some patients, this can also affect nutrient absorption, which is crucial for eye health. This brings us to the importance of considering the full range of effects GLP-1 medications can have on patient health, particularly in managing chronic conditions such as diabetic retinopathy